亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Joint Pharmacophoric Space through Geometric Features

技術優勢
Increased sensitivity and specificity of results Improved beginning investigation point for medicinal chemists
技術應用
Drug design and discoveryMolecular classification
詳細技術說明
Researchers at the University of California, Santa Barbara have proposed a novel method for pharmacophore analysis by examining the Joint Pharmacophore Space (JPS) of chemical compounds, targets, and chemical/biological properties. The underlying geometry of the pharmacophores is responsible for binding between compounds and targets as well as properties of compounds such as Blood Brain Barrier (BBB) permeability. The use of geometric pharmacophoric features allows for the consideration of different conformations of compounds and isolation of the geometry of important pharmacophoric points in these conformations. The benefits of such joint pharmacophore analysis include increased sensitivity and specificity of results, flexibility in posing queries, scaffold hopping, and early in silico prediction and pruning of compounds with undesirable properties.
*Abstract
Pharmacophore analysis through examination of Joint Pharmacophore Space of chemical compounds, targets, and chemical/biological properties.
*Applications
  • Drug design and discovery
  • Molecular classification
*IP Issue Date
Dec 22, 2015
*Principal Investigation

Name: Sayan Ranu

Department:


Name: Ambuj Singh

Department:

申請號碼
9218460
其他

Background

Despite steady and significant increases in R&D spending, an increase in the number of new drug applications and approvals has not been seen. Current target-driven approaches to drug discovery limit focus to a single target and have phenotypic effects such as toxicity and low efficacy that are discovered too late in the discovery process. As a result, current interest is shifting towards evaluating biological properties at the onset and attempting to gain a global understanding of the binding activity between compounds and targets. There have been a number of attempts to understand the relationship between drug chemical structures and target proteins, including pharmacophore based screening. A key weakness of existing pharmacophore based technologies is its ability to analyze compounds only on target-by target basis, aimed at extracting and optimizing a specific pharmacophore. Often, multiple pharmacophoric targets need to be analyzed in the search for drugs against diseases such as cancer or AIDS.


Additional Technologies by these Inventors


Tech ID/UC Case

29289/2011-077-0


Related Cases

2011-077-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備